Valuation : Hologic, Inc.

Market Cap 16.97B 14.62B 13.71B 12.51B 23.58B 1,622B 23.65B 163B 63.46B 819B 63.71B 62.32B 2,715B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 14.98B 14.05B 12.83B 24.16B 1,662B 24.24B 167B 65.04B 839B 65.29B 63.87B 2,782B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+0.86%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 06/04/2026
Director of Finance/CFO - 15/04/2026
Chief Operating Officer 46 31/12/2023
Director TitleAgeSince
Director/Board Member 63 06/04/2026
Date Insider Type Main position Quantity % Market Cap.
07/04/26 Issuer sale

Director

19,583 0.0088%
07/04/26 Issuer sale

General Counsel

72,500 0.0325%
07/04/26 Issuer sale

Executive/Senior Manager

123,246 0.0552%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+14.09%+0.60% 16.97B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
Average -0.74%-1.19%+14.36%+12.50% 81.81B
Weighted average by Cap. -0.44%-1.46%+8.33%+9.12%

Financials

2024 2025
Net sales 4.03B 3.47B 3.26B 2.97B 5.6B 385B 5.62B 38.63B 15.07B 194B 15.13B 14.8B 645B 4.1B 3.53B 3.31B 3.02B 5.7B 392B 5.72B 39.31B 15.34B 198B 15.4B 15.06B 656B
Net income 790M 680M 638M 582M 1.1B 75.46B 1.1B 7.57B 2.95B 38.09B 2.96B 2.9B 126B 566M 487M 457M 417M 786M 54.07B 788M 5.42B 2.12B 27.29B 2.12B 2.08B 90.5B
Net Debt 321M 277M 260M 237M 446M 30.71B 448M 3.08B 1.2B 15.5B 1.21B 1.18B 51.4B 421M 363M 340M 310M 585M 40.23B 587M 4.03B 1.57B 20.31B 1.58B 1.55B 67.33B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock